Structural Modification of an Orally Active Thrombin Inhibitor, LB30057: Replacement of the D-Pocket-binding Naphthyl Moiety
- 1 June 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 6 (6) , 869-876
- https://doi.org/10.1016/s0968-0896(98)00044-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 PositionJournal of Medicinal Chemistry, 1997
- Synthesis of a Series of Potent and Orally Bioavailable Thrombin Inhibitors That Utilize 3,3-Disubstituted Propionic Acid Derivatives in the P3 PositionJournal of Medicinal Chemistry, 1997
- Chapter 6. Thrombin and Factor Xa InhibitionPublished by Elsevier ,1996
- Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam Sulfonamide MoietiesJournal of Medicinal Chemistry, 1996
- Potent Thrombin Inhibitors That Probe the S1‘ Subsite: Tripeptide Transition State Analogues Based on a Heterocycle-Activated Carbonyl GroupJournal of Medicinal Chemistry, 1996
- Thrombin active site inhibitorsBioorganic & Medicinal Chemistry, 1995
- Thrombin inhibitors A new generation of antithromboticsTrends in Cardiovascular Medicine, 1995
- Small-molecule inhibitors of thrombinPerspectives in Drug Discovery and Design, 1994
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profileTrends in Pharmacological Sciences, 1993
- Pharmacology of Synthetic Thrombin Inhibitors of the Tripeptide TypeCardiovascular Drug Reviews, 1992